Featured Speakers

  • Pierre MorettiHead, Cell Line Development Glenmark Pharmaceuticals

  • Dirk NagorsenGlobal Development Leader, Global Clinical Development Amgen

  • Martin SteegmaierHead, Discovery Unit, LMR Roche

  • Sheri MooresPrincipal Scientist Janssen

Develop Potent, Targeted and Robust Bispecific Products

Access revelations that will slash your time to the clinic as the world’s leading bispecific experts gather in Boston.

This year’s 5th World Bispecific Antibody Summit has been designed to empower you, whatever your background, technology or approach, to increase your speed to the clinic. Meet the industry’s finest as we debate the best ways to identify your lead candidate, optimize the drug-like properties and maximize the clinical performance of your bispecific drugs.

Click here to download the meeting agenda to see the full speaker line up and presentation details.

Top 10 Reasons to Attend:

1. Discover which novel target biologies Abbvie have validated as amenable to bispecific therapy
2. Learn how Genmab are robustly scaling up processing and manufacturing of their constructs
3. Amgen will present the latest intelligence from their in-human studies of Blinatumomab
4. Listen to Macrogenics showcase their exploratory work to modulate B lymphocytes in the management of AI disorders
5. Ablynx will share the assay methodologies they have been using to support the progression of their pipeline

If those have already whet your appetite, download the full agenda to read all about these presentations in more detail. Or, read on for even more temptation...

6. Boost efficacy of your bispecific through drug conjugation and leverage extensive experience from Zymeworks
7. MedImmune will detail their immense progress in targeted and treated viral and other pathogenic illnesses
8. Gain a detailed understanding of how BMS are optimizing the biophysical characteristics of their formats through development
9. Assess how Glenmark have boosted cell line expression and used this to produce their drug on a several g/L scale
10. Hear how Genentech perform their non-clinical toxicology studies across all their bispecific programs

Download the agenda

You will access knowledge from the most advanced companies and people in the field. You’ll listen to them talk, of course. But interactive discussions and innovative networking formats, mean you can get the answers to your specific questions.

What Next?

 

Join us Online